MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
Year: 2015
Type: article
Source: PubMed
Authors: Lijuan Yao, Li Wang, Fengxia Li, Xihai Gao, Xuegong Wei, Zhihui Liu
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2414425258